GLP-1 drugs, such as Ozempic and Wegovy, may slightly increase the risk of osteoporosis, gout, and the rare metabolic bone disease osteomalacia, a recent study suggests.
GLP-1 drugs, such as Ozempic and Wegovy, may slightly increase the risk of osteoporosis, gout, and the rare metabolic bone disease osteomalacia, a recent study suggests.
As these conditions are all related to bones and joints, the study's researchers... [3745 chars]